Accès à distance ? S'identifier sur le proxy UCLouvain
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Primary tabs
Document type | Article de périodique (Journal article) |
---|---|
Access type | Accès restreint |
Publication date | 2012 |
Language | Anglais |
Journal information | "New England Journal of Medicine" - Vol. 367, no. 25, p. 2407-2418 (2012) |
Peer reviewed | yes |
Publisher | Massachusetts Medical Society ((United States) [S.l.]) |
issn | 0028-4793 |
e-issn | 1533-4406 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/NEFR - Pôle de Néphrologie UCL - (SLuc) Service de néphrologie |
MESH Subject | Adolescent ; Middle Aged ; Organ Size ; Polycystic Kidney, Autosomal Dominant ; Receptors, Vasopressin ; Sodium ; Young Adult ; Adult ; Benzazepines ; Double-Blind Method ; Female ; Glomerular Filtration Rate ; Humans ; Kidney ; Male |
Links |
Bibliographic reference | Torres, Vicente E ; Chapman, Arlene B ; Devuyst, Olivier ; Gansevoort, Ron T ; Grantham, Jared J ; et. al. Tolvaptan in patients with autosomal dominant polycystic kidney disease.. In: New England Journal of Medicine, Vol. 367, no. 25, p. 2407-2418 (2012) |
---|---|
Permanent URL | http://hdl.handle.net/2078/125023 |